| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,053,680 | 1 | 3 |
Sells | $141,321,268 | 37 | 97 |
| Lightcap Jeffrey C | director | 1 | $1.05M | 0 | $0 | $1.05M |
| Cullivan Julie A | director | 0 | $0 | 2 | $446,610 | $-446,610 |
| Verghese Vikram | Chief Financial Officer | 0 | $0 | 8 | $4.98M | $-4.98M |
| Rogers Campbell | Chief Medical Officer | 0 | $0 | 8 | $8.03M | $-8.03M |
| Farquhar John C.M. | Chief Executive Officer | 0 | $0 | 15 | $12.87M | $-12.87M |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 0 | $0 | 4 | $115M | $-115M |
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's …
Over the last 12 months, insiders at Heartflow, Inc. Common Stock have bought $1.05M and sold $141.32M worth of Heartflow, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Heartflow, Inc. Common Stock have bought $1.05M and sold $141.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lightcap Jeffrey C (director) — $1.05M.
The last purchase of 40,000 shares for transaction amount of $1.05M was made by Lightcap Jeffrey C (director) on 2025‑12‑16.
| 2026-10-22 | Sale | Rogers Campbell | Chief Medical Officer | 23,933 0.0275% | $55.01 | $1.32M | +3.58% | |
| 2026-10-12 | Sale | Farquhar John C.M. | Chief Executive Officer | 38,900 0.0441% | $49.57 | $1.93M | +9.79% | |
| 2026-09-18 | Sale | Verghese Vikram | Chief Financial Officer | 16,766 0.0194% | $50.75 | $850,926 | -0.60% | |
| 2026-09-18 | Sale | Rogers Campbell | Chief Medical Officer | 19,682 0.0226% | $50.15 | $987,052 | -0.60% | |
| 2026-09-17 | Sale | Verghese Vikram | Chief Financial Officer | 7,579 0.0089% | $50.11 | $379,816 | +2.00% | |
| 2026-09-15 | Sale | Verghese Vikram | Chief Financial Officer | 668 0.0008% | $50.01 | $33,408 | +4.14% | |
| 2026-09-14 | Sale | Verghese Vikram | Chief Financial Officer | 4,593 0.0054% | $50.24 | $230,744 | +1.58% | |
| 2026-09-11 | Sale | Farquhar John C.M. | Chief Executive Officer | 3,890 0.0045% | $50.00 | $194,500 | +0.88% | |
| 2026-09-11 | Sale | Verghese Vikram | Chief Financial Officer | 29,714 0.0345% | $50.06 | $1.49M | +0.88% | |
| 2026-09-10 | Sale | Farquhar John C.M. | Chief Executive Officer | 35,010 0.0413% | $46.42 | $1.63M | +10.45% | |
| 2026-09-08 | Sale | Verghese Vikram | Chief Financial Officer | 6,640 0.0081% | $50.03 | $332,212 | +4.81% | |
| 2026-09-03 | Sale | Verghese Vikram | Chief Financial Officer | 27,540 0.0319% | $49.69 | $1.37M | +0.38% | |
| 2026-09-02 | Sale | Verghese Vikram | Chief Financial Officer | 5,876 0.0069% | $50.60 | $297,326 | -0.24% | |
| 2026-08-21 | Sale | Farquhar John C.M. | Chief Executive Officer | 27,230 0.0317% | $50.00 | $1.36M | +0.28% | |
| 2026-08-18 | Sale | Farquhar John C.M. | Chief Executive Officer | 32,676 0.0377% | $45.00 | $1.47M | +10.23% | |
| 2026-08-17 | Sale | Rogers Campbell | Chief Medical Officer | 9,219 0.0105% | $41.23 | $380,099 | +18.81% | |
| 2026-08-14 | Sale | Farquhar John C.M. | Chief Executive Officer | 15,560 0.0167% | $39.06 | $607,774 | +18.32% | |
| 2026-08-10 | Sale | Farquhar John C.M. | Chief Executive Officer | 22,562 0.0059% | $28.31 | $638,730 | +69.49% | |
| 2026-07-15 | Sale | Rogers Campbell | Chief Medical Officer | 9,219 0.0101% | $25.72 | $237,113 | +79.54% | |
| 2026-07-10 | Sale | Farquhar John C.M. | Chief Executive Officer | 22,562 0.0272% | $27.75 | $626,096 | +83.05% |
| Increased Positions | 88 | +103.53% | 12M | +27.47% |
| Decreased Positions | 36 | -42.35% | 4M | -9.55% |
| New Positions | 50 | New | 4M | New |
| Sold Out Positions | 24 | Sold Out | 3M | Sold Out |
| Total Postitions | 137 | +61.18% | 52M | +17.92% |